Cosmos Pharmaceutical Corp
TSE:3349

Watchlist Manager
Cosmos Pharmaceutical Corp Logo
Cosmos Pharmaceutical Corp
TSE:3349
Watchlist
Price: 6 911 JPY 2.84% Market Closed
Market Cap: 547.7B JPY
Have any thoughts about
Cosmos Pharmaceutical Corp?
Write Note

Cash Flow Statement

Cash Flow Statement
Cosmos Pharmaceutical Corp

Rotate your device to view
Cash Flow Statement
Currency: JPY
Feb-2006 Aug-2006 Feb-2007 Aug-2007 Feb-2008 Aug-2008 Feb-2009 Aug-2009 Feb-2010 Aug-2010 Nov-2010 Feb-2011 May-2011 Nov-2011 May-2012 Nov-2012 May-2013 Nov-2013 May-2014 Nov-2014 May-2015 Nov-2015 May-2016 Nov-2016 May-2017 Nov-2017 May-2018 Nov-2018 May-2019 Nov-2019 May-2020 Nov-2020 May-2021 Nov-2021 May-2022 Nov-2022 May-2023 Nov-2023 May-2024
Operating Cash Flow
Net Income
1 139
224
250
20
(47)
(657)
276
1 866
2 835
253
2 555
1 506
4 579
12 881
14 398
15 987
16 652
17 756
18 416
17 762
19 420
20 285
20 496
24 226
25 737
23 279
25 167
26 931
27 139
26 813
30 402
36 678
38 596
36 011
33 048
33 176
32 773
33 222
33 719
Depreciation & Amortization
145
55
152
48
170
41
177
134
423
100
655
329
1 015
2 679
3 104
3 655
4 247
4 867
5 604
6 324
7 342
8 519
9 588
10 223
10 710
11 248
11 885
12 510
12 958
13 318
13 562
13 674
13 785
14 162
15 110
16 262
17 368
18 533
19 924
Other Non-Cash Items
30
(52)
(45)
(98)
(118)
89
90
17
14
421
437
423
483
125
128
102
99
179
(173)
(243)
150
173
193
(139)
(1 133)
80
96
315
158
97
1 162
1 323
(2 758)
(3 227)
(187)
87
315
328
636
Cash Taxes Paid
308
567
942
(368)
(360)
12
40
568
795
1 232
1 232
2 013
2 014
5 086
5 595
6 726
7 641
7 399
7 503
7 938
8 050
7 546
7 427
8 006
8 680
8 355
8 300
7 930
7 503
8 112
8 369
9 035
9 103
11 326
13 337
10 223
9 111
9 312
8 993
Cash Interest Paid
(24)
(5)
3
5
12
(2)
(6)
3
18
(1)
29
(15)
11
98
82
69
58
51
50
53
56
66
91
104
98
93
88
82
78
74
68
64
60
56
52
48
51
63
101
Change in Working Capital
(285)
(1 238)
(2 243)
3 151
3 596
1 124
126
(3 820)
(6 960)
1 327
286
3 265
8 292
(2 154)
(1 536)
(895)
(2 232)
(5 173)
2 113
2 416
(7 458)
(6 553)
709
(11)
1 623
880
(4 562)
(8 808)
(5 877)
(2 021)
20 335
(740)
(21 750)
(11 351)
(15 777)
(7 553)
3 978
2 451
896
Cash from Operating Activities
1 029
N/A
(1 011)
N/A
(1 886)
-87%
3 121
N/A
3 601
+15%
597
-83%
669
+12%
(1 803)
N/A
(3 688)
-105%
2 101
N/A
3 933
+87%
5 523
+40%
14 369
+160%
13 531
-6%
16 094
+19%
18 849
+17%
18 766
0%
17 629
-6%
25 960
+47%
26 259
+1%
19 454
-26%
22 424
+15%
30 986
+38%
34 299
+11%
36 937
+8%
35 487
-4%
32 586
-8%
30 948
-5%
34 378
+11%
38 207
+11%
65 461
+71%
50 935
-22%
27 873
-45%
35 595
+28%
32 194
-10%
41 972
+30%
54 434
+30%
54 534
+0%
55 175
+1%
Investing Cash Flow
Capital Expenditures
129
(1 721)
(3 642)
1 666
3 222
(886)
(1 357)
769
1 190
(379)
(2 335)
(2 221)
(3 408)
(6 661)
(11 138)
(14 787)
(18 030)
(20 803)
(20 144)
(22 828)
(29 865)
(33 207)
(31 092)
(28 345)
(28 667)
(28 674)
(29 451)
(29 645)
(29 040)
(27 556)
(25 948)
(22 053)
(26 064)
(35 601)
(43 497)
(45 628)
(46 636)
(53 853)
(55 810)
Other Items
(274)
80
(176)
(391)
(320)
246
179
(81)
498
165
(282)
(339)
(1 170)
(1 891)
(509)
(137)
(602)
(525)
26
(214)
593
2 432
2 542
1 334
263
(335)
(1 007)
(1 141)
(1 002)
(921)
(1 008)
(946)
6 683
7 828
(220)
(2 013)
(2 477)
(2 510)
(1 519)
Cash from Investing Activities
(145)
N/A
(1 641)
-1 032%
(3 818)
-133%
1 275
N/A
2 902
+128%
(640)
N/A
(1 178)
-84%
688
N/A
1 688
+145%
(214)
N/A
(2 617)
-1 123%
(2 560)
+2%
(4 578)
-79%
(8 552)
-87%
(11 647)
-36%
(14 924)
-28%
(18 632)
-25%
(21 328)
-14%
(20 118)
+6%
(23 042)
-15%
(29 272)
-27%
(30 775)
-5%
(28 550)
+7%
(27 011)
+5%
(28 404)
-5%
(29 009)
-2%
(30 458)
-5%
(30 786)
-1%
(30 042)
+2%
(28 477)
+5%
(26 956)
+5%
(22 999)
+15%
(19 381)
+16%
(27 773)
-43%
(43 717)
-57%
(47 641)
-9%
(49 113)
-3%
(56 363)
-15%
(57 329)
-2%
Financing Cash Flow
Net Issuance of Common Stock
2 788
0
(5 578)
0
(175)
0
0
0
0
0
0
0
0
0
0
0
0
0
(1)
(1)
0
0
0
0
0
0
0
0
0
0
0
0
0
(1)
(2)
(1)
0
0
0
Net Issuance of Debt
(3 400)
2 997
4 731
(1 392)
(1 314)
(1 948)
(529)
141
(1 545)
(27)
(1 050)
(2 355)
(3 156)
(3 037)
(2 820)
(2 699)
(2 491)
761
639
2 154
8 291
15 856
7 452
(7 108)
(6 701)
(6 327)
(6 405)
(6 171)
(5 200)
(3 937)
(3 326)
(3 262)
(3 228)
(3 218)
(2 952)
(2 994)
6 514
5 815
13 187
Cash Paid for Dividends
(97)
(65)
(65)
0
0
2
2
(100)
(100)
(158)
(158)
(158)
(158)
(692)
(1 049)
(792)
(831)
(989)
(1 088)
(1 088)
(1 138)
(1 188)
(1 237)
(1 286)
(1 385)
(1 583)
(1 781)
(1 781)
(1 781)
(1 980)
(2 077)
(2 175)
(2 277)
(2 772)
(3 266)
(3 167)
(3 266)
(3 962)
(4 659)
Other
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(2)
(3)
(1)
(3)
(2)
(2)
(2)
(1)
(4)
(4)
(2)
(1)
(2)
(2)
(1)
(1)
(2)
(2)
(2)
(2)
(2)
(3)
(3)
(2)
(1)
Cash from Financing Activities
(709)
N/A
2 932
N/A
(912)
N/A
(1 392)
-53%
(1 489)
-7%
(1 946)
-31%
(352)
+82%
41
N/A
(1 645)
N/A
(185)
+89%
(1 208)
-553%
(2 513)
-108%
(3 314)
-32%
(3 729)
-13%
(3 871)
-4%
(3 494)
+10%
(3 323)
+5%
(231)
+93%
(452)
-96%
1 063
N/A
7 151
+573%
14 667
+105%
6 211
-58%
(8 398)
N/A
(8 088)
+4%
(7 911)
+2%
(8 188)
-4%
(7 954)
+3%
(6 982)
+12%
(5 918)
+15%
(5 405)
+9%
(5 439)
-1%
(5 507)
-1%
(5 993)
-9%
(6 222)
-4%
(6 165)
+1%
3 245
N/A
1 851
-43%
8 527
+361%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Change in Cash
175
N/A
280
+60%
(6 616)
N/A
3 004
N/A
5 014
+67%
(1 989)
N/A
(861)
+57%
(1 074)
-25%
(3 645)
-239%
1 702
N/A
108
-94%
450
+317%
6 477
+1 339%
1 250
-81%
576
-54%
431
-25%
(3 189)
N/A
(3 930)
-23%
5 390
N/A
4 280
-21%
(2 667)
N/A
6 316
N/A
8 647
+37%
(1 110)
N/A
445
N/A
(1 433)
N/A
(6 060)
-323%
(7 792)
-29%
(2 646)
+66%
3 812
N/A
33 100
+768%
22 497
-32%
2 985
-87%
1 829
-39%
(17 745)
N/A
(11 834)
+33%
8 566
N/A
22
-100%
6 373
+28 868%
Free Cash Flow
Free Cash Flow
1 158
N/A
(2 732)
N/A
(5 528)
-102%
4 787
N/A
6 823
+43%
(289)
N/A
(688)
-138%
(1 034)
-50%
(2 498)
-142%
1 722
N/A
1 598
-7%
3 302
+107%
10 961
+232%
6 870
-37%
4 956
-28%
4 062
-18%
736
-82%
(3 174)
N/A
5 816
N/A
3 431
-41%
(10 411)
N/A
(10 783)
-4%
(106)
+99%
5 954
N/A
8 270
+39%
6 813
-18%
3 135
-54%
1 303
-58%
5 338
+310%
10 651
+100%
39 513
+271%
28 882
-27%
1 809
-94%
(6)
N/A
(11 303)
-188 283%
(3 656)
+68%
7 798
N/A
681
-91%
(635)
N/A

See Also

Discover More